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Abstract 
Light weight stocker calves often experience health problems shortly after arrival to feeding facilities. 
Preventative health programs are routinely administered to calves upon arrival to reduce the incidence of 
Bovine Respiratory Disease. The major route of vaccine administration in cattle is via injection through 
either intramuscular or subcutaneous routes. Several products have been introduced that utilize the 
intranasal route of vaccine administration. There are several reasons why intranasal vaccine 
administration may be more beneficial: 1) Intranasal vaccine administration alleviates concerns that 
injections pose for Beef Quality Assurance programs. 2) Intranasal vaccine administration may be less 
stressful on the animal. 3) Intranasal vaccine administration delivers the vaccine to the site of infection in 
the case of respiratory pathogens, and may provide a different adaptive immune response to the vaccine. 
The objective of this study was to determine the effects of route of administration of the Mannheimia 
haemolytica and Pasteurella multocida fractions of the vaccine regimen on receiving cattle growth 
performance, health, and mortality. 
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Route of Mannheimia haemolytica 
and Pasteurella multocida Vaccine 
Administration Does Not Affect Health or 
Performance of Receiving Heifers
T.J. Spore, M.E. Corrigan1, T.R. Parks1,C.S. Weibert, M.L. DeTray,  
W.R. Hollenbeck, R.N. Wahl, and D.A. Blasi
Introduction
Light weight stocker calves often experience health problems shortly after arrival to 
feeding facilities. Preventative health programs are routinely administered to calves 
upon arrival to reduce the incidence of Bovine Respiratory Disease. The major route of 
vaccine administration in cattle is via injection through either intramuscular or subcu-
taneous routes. Several products have been introduced that utilize the intranasal route 
of vaccine administration. There are several reasons why intranasal vaccine administra-
tion may be more beneficial: 1) Intranasal vaccine administration alleviates concerns 
that injections pose for Beef Quality Assurance programs. 2) Intranasal vaccine ad-
ministration may be less stressful on the animal. 3) Intranasal vaccine administration 
delivers the vaccine to the site of infection in the case of respiratory pathogens, and may 
provide a different adaptive immune response to the vaccine.
The objective of this study was to determine the effects of route of administration of the 
Mannheimia haemolytica and Pasteurella multocida fractions of the vaccine regimen on 
receiving cattle growth performance, health, and mortality.
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Experimental Procedures
A total of 388 cross-bred heifers (497 ± 32 lb) were purchased from sale barns in MO 
and TN and received in 4 truckloads to the Kansas State University Beef Stocker Unit. 
Two truckloads were received on March 23, one truckload was received on March 30, 
and one truckload was received on April 2, 2016. Cattle were weighed immediately af-
ter coming off the truck, individually identified with an ear tag, and an ear notch sample 
was taken for testing of persistent infection with Bovine Viral Diarrhea Virus. Three 
animals tested positive and were excluded from the experiment. Other exclusion criteria 
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included the presence of active disease, injury, or disparities in body weight relative to 
the other animals from the truckload. 
The day following arrival, all cattle were weighed again and given their respective inves-
tigational vaccines and Vision 7 Somnus (Merck Animal Health, Madison, NJ), Ivomec 
Plus (Merial, Duluth, GA), Safe-Guard (Merck Animal Health, Madison, NJ) and 
Exede (Zoetis, Parsippany, NJ). This weight served as the initial weight for the experi-
ment.
Truckload served as the blocking factor and cattle within a truckload were stratified by 
arrival weight and randomly assigned to pens of 11 to 13 head. Pens were then random-
ly assigned to one of 2 treatments with 16 pens per treatment. Treatments consisted of 
Vista Once SQ (Merck Animal Health, Madison, NJ) given subcutaneously at initial 
processing or Vista 5 SQ (Merck Animal Health, Madison, NJ) given subcutaneously 
plus Once PMH IN (Merck Animal Health, Madison, NJ) administered intranasally at 
initial processing.
Diets were provided in quantities to ensure ad libitum intake. Body weights were 
captured at initial processing, during revaccination (day 14), and at completion of the 
study, which was day 47 for blocks 1 and 2 and day 45 for blocks 3 and 4. All calves 
were observed daily for any signs of sickness or lameness. If any signs were observed, 
cattle were pulled from their pens and a rectal temperature was taken. If a temperature 
of 104°F or higher was found, antibiotics were administered according to the Kansas 
State University Beef Stocker Unit health protocol. Diagnosis of non-bovine respira-
tory diseases (lameness, pink eye, etc.) was treated according to the health protocol. 
During the course of the trial, 1 animal from the Vista Once SQ group was found 
dead in the pen from bronchopneumonia. Additionally, 4 heifers were removed for 
mycoplasma infections or injury. Of these animals, 2 were in the Vista Once SQ group 
and 2 were in the Vista 5 SQ plus Once PMH IN group. These animals were excluded 
from the analysis. Data were analyzed as a randomized complete block design using the 
MIXED procedure of SAS (version 9.3; SAS Institute, Cary, NC). Pen was the experi-
mental unit. In the model, treatment was a fixed effect and block was a random effect. 
Treatment differences were considered significant at P-value less than 0.05 and tenden-
cies at P-value less than 0.10.
Results and Discussion
The effects of route of vaccine administration are shown in Table 1. Overall, the cattle 
performed well on feed between all treatments. There were no differences in body 
weight gain, average daily gain, feed intake, feed efficiency, morbidity, or mortality dur-
ing the receiving trial. Morbidity and mortality were lower than anticipated in this class 
of cattle. 
Implications
Route of vaccine administration in cattle experiencing a low disease challenge did not 
impact performance or health measurements.
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Table 1. Performance and health of cattle vaccinated with VISTA Once SQ given subcu-
taneously or VISTA 5 SQ given subcutaneously together with ONCE PMH-IN adminis-
tered intranasally
Item
Vista 5 SQ and 
Once PMH IN Vista Once SQ SEM1 P-value
Initial weight, lb 498 499 1.3 0.77
14-Day performance
Body weight, lb 534 531 2.8 0.39
Dry matter intake, lb 10.8 11.0 0.13 0.36
Average daily gain, lb 2.53 2.32 0.196 0.29
Gain:feed 0.232 0.212 0.0181 0.25
45-Day performance
Final weight, lb 593 593 3.9 0.96
Dry matter intake, lb 11.9 12.0 0.13 0.50
Average daily gain, lb 2.06 2.05 0.083 0.83
Gain:feed 0.174 0.171 0.0069 0.66
Health
1st Pulls 4.1% 3.6% 0.17 0.73
2nd Pulls 0.01% 0.01% 0.008 0.55
Mortality 0% 0.005% 0.0064 1.00
1SEM=Standard error of the mean.
